Pentasa is a crucial medication for managing chronic inflammatory bowel diseases, especially for those suffering from ulcerative colitis. While it has proven benefits, it must be used under medical supervision due to potential side effects, especially with long-term use.
Pentasa contains Mesalazine (also known as 5-aminosalicylic acid), which is primarily used in the treatment of inflammatory bowel diseases like Ulcerative Colitis and Crohn's Disease. It helps reduce inflammation in the intestines and is effective in maintaining remission and treating flare-ups.
Side Effects:
Common side effects: Abdominal pain, diarrhea, nausea, and headache.
Serious side effects: Blood disorders (e.g., anemia, leukopenia), kidney problems, liver issues, and pancreatitis.
Rare side effects: Allergic reactions, such as rash, fever, and difficulty breathing.
Precautions:
Allergic reactions: Individuals allergic to Mesalazine or other non-steroidal anti-inflammatory drugs (NSAIDs) should avoid use.
Kidney and liver issues: Caution is required in patients with pre-existing kidney or liver conditions, as Pentasa may affect their function.
Pregnancy and breastfeeding: Consult a healthcare provider before using Pentasa during pregnancy or while breastfeeding.
Long-term use: Regular monitoring of kidney function is recommended for patients on long-term treatment with Pentasa.
Uses:
Treatment and maintenance of Ulcerative Colitis and Crohn's Disease.
Inducing remission in patients with active inflammation.
Benefits:
Reduces inflammation in the intestines and helps control flare-ups.
Helps maintain remission in patients with inflammatory bowel diseases, preventing relapses.
Adult Dosage: Typically, 1 gm taken 3-4 times a day, depending on the severity of the condition and the physician's recommendation.
